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Introduction

P i n d o l o l ( ( 2R S ) -( 1 -( 1 H-i n d o l -4 -i l o x y ) -3-[ ( 1 -m e t y l o e t y l o )
amino]-2-propanol) is a β-adrenolytic drug and a d e r i v a t i v e o f a r y l a l k y l a m i n o p r o p a n o l . T h e a l k y l substituent at the amino group is an isopropyl group, while the aryl part consists of two rings which determines the nonselective effect on β 1 and β 2 -adrenergic receptors. Pindolol is applied for the treatment of hypertension, both in monotherapy and in combination therapy, of supraventricular cardiac arrhythmia, of hyperkinetic circulation complex and as an adjunctive drug in hyperthyroidism. It is also used in the treatment of glaucoma as it helps reduce the intraocular pressure. It is administered in the form of tablets or eye drops, and the use of these formulations requires earlier sterilisation. This procedure can be performed by one of the methods recommended by pharmacopoeia, among which radiation sterilisation has become increasingly attractive [ 1 ,2] . The problem is that the use of radiation sterilisation involves a risk of changes caused by irradiation in the therapeutic substance. So each time, the formulation is irradiated, the effects of irradiation should be checked by detailed instrumental analysis.
In our earlier studies, the effect of irradiation was evaluated by physicochemical methods, TLC, DSC, and XRD for six β-blockers (alprenolol, acebutolol, atenolol, metoprolol, pindolol and propranolol) . The results have shown that after irradiation with 25 kGy pindolol, along with acebutolol and propranolol, revealed small changes manifested by a decrease in the melting point (by 0.3°C for 25 kGy and by 1.8°C for 400 kGy) and a subtle change in colour -from white to light cream (25 kGy) or beige after irradiation with the highest dose applied (400 kGy) [ 3] . These changes can be related to the formation of free radicals [4 ,5 ] 
in substantia was exposed to ionising radiation emitted by high energy electrons from an accelerator, in the standard sterilisation dose of 25 kGy and in higher doses from the range 50−400 kGy. The effects of irradiation were checked by spectrometric methods (UV, MS, FT-IR, EPR) and hyphenated methods (HPLC-MS) and the results were referred to those obtained for non-irradiated sample. EPR results indicated the presence of free radicals in irradiated samples, in the amount of 1.36 × 10 16 spin g -1 for 25 kGy and 3.70×10 16 spin g -1 for 400 kGy. The loss of pindolol content determined by HPLC was 1.34% after irradiation with 400 kGy, while the radiolytic yield of the total radiolysis for this dose of irradiation was 2.69×10 7 mol J -1
. By means of HPLC-MS it was possible to separate and identify one product of radiolytic decomposition, which probably is 2-((R)-3-(1H-indol-4-yloxy)-2-hydroxypropylamino)propan-1-ol formed upon oxidation.
In the range of sterilisation doses (25-50 kGy), pindolol was found to show high radiochemical stability and would probably be safely sterilised by the standard dose of 25 kGy.
The studies reported in this work were undertaken to explain the origin of the above changes. Pindolol in substantia was irradiated with ionising radiation emitted by a beam of electrons of 9.96 MeV energy, in doses of 25 kGy (which is a standard sterilisation dose recommended by the pharmacopoeia) and 50, 100, 200 and 400 kGy, to be able to detect changes that could be undetectable upon irradiation with lower doses.
Experimental procedure
Materials and standards
symbol PD, molecular weight 248.32, CAS number 13523-86-9, Pharmaceutical Production Company SigmaAldrich (Fig. 1 ) .
Pindolol European Pharmacopeia Standard, LGC S t a n d a r d s .
Methods
Irradiation with E-beam radiation
Approximately, 0.5 g of PD was placed in colourless glass jars of 3 mL volume and closed with a plastic stopper. They were irradiated with 25, 50, 100, 200, 400 kGy using a linear electron accelerator LAE 13/9, with electron energy of 9.96 MeV and current intensity 6.2 mA.
Electron Paramagnetic Resonance Spectroscopy (EPR)
The EPR experiments were carried out for non-irradiated and irradiated samples in standard EPR quartz sample tubes from Wilmad. The measurements were performed with a Bruker EPR EMX-10 spectrometer working at 9.4 GHz (X-band) at room temperature (293 K). The sensitivity of the spectrometer is 1×10 10 s p i n s p e r gram. Induction of the magnetic field was measured to an accuracy of 0.001 mT. Microwave frequency was measured to an accuracy of 0.001GHz. The spectra were double integrated over the magnetic field range 334-354 mT which gives a figure proportional to the number of radicals in the sample.
Fourier transforms infrared spectroscopy (FTIR)
The FTIR study was performed for non-irradiated and irradiated samples weighed in 1 mg portions of PD and for 300 mg of potassium bromide dried at 600°C for 4 h and compressing it with Pye Unicam minipress. The spectra were recorded using a Bruker FT-IR spectrometer in the range of 400-4000 cm -1 against the reference sample.
UV Spectrophotometry
The solutions were prepared by dissolving the substance in methanol at a concentration of 0.020% w/v. The solutions were examined using a UV/VIS PERKIN ELMER Lambda 20 spectrophotometer, in 1 cm cells in the range 200 -400 nm, using water as a blank. For the concentrations in the range 0.005 -0.045%, the calibration curve was determined to be expressed by Y = 339.42 x (l m a x = 264 nm) and characterised by the correlation coefficient of 0.9993. The precision of the method is described by RSD = 1.16%. The method was validated according to the ICH recommendations [7 ] .
High-performance liquid chromatography (HPLC)
HPLC measurements were performed with a capillary column (3 mm) of Xterra C18, of length 250×4.6 mm, with a mobile phase composition: H 2 O, containing 0.5% formic acid v/v and acetonitrile containing 0.5% formic acid v/v (20:80 v/v). The flow rate was 1.0 mL min -1 , void volume [8] (V 0 ) = 2.91 mL, and the detector wavelength w a s l m a x =224-230 nm. The measurements were made on a Merck-Hitachi. Separation was performed at room temperature. Within the concentration range of 0.5×10 -2 to 14.0×10 -2 mg cm -3 , the method was linear, characterised by a satisfactory correlation coefficient (r = 0.9977), and high precision (RSD = 1.07%). The limit of detection, LOD, is 0.011 mg cm -3 , while the limit of quantification, LOQ, is 0.032 mg cm 
Liquid chromatography-mass spectrometry (LC/ESI/MS n ) analysis
LC/ESI/MS n analysis was performed using an Agilent 1100 HPLC instrument (Palo Alto, CA, USA) combined with an ion trap (IT) mass spectrometer, model Esquire 3000 (Bruker Daltonics, Bremen, Germany). Chromatographic separations were carried out using an X-Bridge RP-18 column (150×2 mm, 3 µm grain diameter; Waters), at a 0.2 mL min -1 flow rate, the samples were injected through a 20 µL injection loop. The analysed compounds were eluted from the LC column using mixtures of two solvents: A (H 2 O, containing 0.5% formic acid v/v) and B (acetonitrile containing 0.5% formic acid, v/v). The gradient elution steps were as follows: 0-1 min isocratic at 5% B, 1-25 min linear gradient from 5 to 40% of B, 25-26 min linear gradient up to 98% of B, 26-29 min isocratic at 98% of B followed by a return to the starting conditions and the column equilibration steps.
The mass spectrometer was equipped with an electrospray ionization (ESI) source. The analyses were conducted in the positive ion mode with the source parameters as follows: ESI source voltage of 4.5 kV, nebulization with nitrogen at 27 psi, dry gas flow of 7.0 L min -1 at temperature of 310°C. The skimmer 1 voltage was set to 27.1 V, and the collision energy of 1 V was ramped between 40% and 400% of this value, and the mass spectra were measured within the 50-750 m/z range. Helium was used as the collision gas. The instrument operated under EsquireControl version 5.1, and data were analysed using the Data Analysis version 3.1 package delivered by Bruker.
Mass spectrometry (MS)
The EI mass spectra were recorded on an AMD-402 two-sector mass spectrometer (AMD Intectra, Germany) with an acceleration voltage of 8 kV, an electron energy of 70 eV and an ion source temperature of 200°C.
Results and discussion
According to EPR results, the pindolol (PD) samples in substantia exposed to ionising irradiation emitted by high energy electrons were found to contain free radicals in the concentrations of 1.36×10 1 6 spin g -1 -25 k G y a n d 3.70×10 1 6 spin g -1 -400 kGy (Fig. 2) . Until today, no norms have been established as to the content of free radicals in pharmaceutical substrates and preparations. However, these values were found comparable with the contents of free radicals measured for other groups of drugs (alkaloids, sulphonamides, antibiotics, imidazoline derivatives) exposed to ionising irradiation under the same conditions [1 1 -1 5 ]. The observed change in colour of the irradiated PD samples from white to light cream can be a result of the appearance of free radicals [1 6 ], colour products of radiolysis or by defects in the crystal lattice [1 3,1 7 -19]. Because the solutions of the colour substance were colourless and there were no changes in the XRD diffractograms [3] , it suggest that the change in colour is a result of irradiation most probably not related to the defects in the crystal lattice. The colour changes were not accompanied by changes in the FT-IR spectrum which was fully consistent with the standard before irradiation [20] , and after irradiation with doses 25 -400 kGy, no important changes were noted in positions or intensities of the characteristic absorption bands. Also no band disappearance or appearance of new bands was observed (Fig. 3) . Significant changes were found in the UV-VIS spectra of methanol solutions of irradiated PD samples. At the analytical wavelength of l m a x = 264 nm, an increase in absorption was noted of 4.96% for 200 kGy and 8.97% for 400 kGy ( Table 1 ). This change can indirectly indicate the formation of radiodegradation products whose structures are similar to that of the parent compound.
HPLC measurements permitted identification of the decomposition product ( t R = 2.65 min), and this method was also applied for quantitative analysis. No loss in the PD content was noted after irradiation with the standard irradiation dose of 25 kGy and 50 or 100 kGy. A small loss in PD content 0.52% ± 0.07% was observed after irradiation with 200 kGy, and it increased to 1.34±0.07% after irradiation with 400 kGy (a dose 16 times greater than the standard one) (Fig. 4 ) .
These observations suggest that the colour changes of irradiated PD could be a result of formation of coloured products of radiolysis, while the disappearance of the colour after dissolving irradiated PD in methanol could be explained by small amounts of the products formed.
On the basis of the measurements, the radiolytic yield of PD radiodegradation upon irradiation was calculated to vary from 2.09×10 7 m o l J -1 for 200 kGy to 2.69×10 7 m o l J -1 for 400 kGy ( Table 1 ) . According to literature [1 3,1 6 ,21 -22], the radiolytic yield of therapeutic drugs in solid is usually of the order of 10 7 -10 8 m o l J -1 , so that of PD in solid state is close or a bit smaller than the values obtained for other therapeutic drugs exposed to the same type of radiation. Increase in the radiolytic yield with increasing irradiation dose is, most probably, related to further radiolytic degradation of the studied compound [23] [24] [25] .
The PD samples before irradiation were subjected to HPLC-MS n analysis in positive ionisation (ES+), and the mass spectrum revealed the presence of a molecular ion at m/z 249 [M+H] (Fig. 6 ) a s w e l l a s a scheme of radiodegradation of PD in solid state (Fig. 7 ) . Similar processes of radiolysis have been observed in other therapeutic drugs (ketoprofen, prednisolone, cefalosporine) exposed to ionising i r r a d i a t i o n [ 4 ,1 7 ]. The PD radiodegradation product of the molecular mass 264.4 is not known as a pharmacopoeia impurity [1 ,2] or metabolite [26 ,27 ] , so only its isolation and biological study could ascertain if it shows pharmacological or toxic activity or if its activity is similar to that of the parent compound.
The MS spectra were also taken after irradiation with 400 kGy with the intention to find signals corresponding to new ions indicating the presence of product A ([M] + =265 m/z), but no new signals were found, only some insignificant changes in the intensities of a few peaks were observed. This result could be related to a small amount of the radiolysis products (0.5 -1.34%) or too low sensitivity of the instruments used. The data characterising the MS spectra are given in Table 2 , and the proposed structures of ions formed -in Table 3 . 
Conclusion
Results of the studies performed permit the conclusion that PD in solid state is resistant to ionising radiation (E-beam) in a standard sterilisation dose of 25 kGy, and this method can safely be used for sterilisation and decontamination of this compound. Irradiation with higher doses leads to the following effects:
• small change in colour of PD related to the presence of radiolysis products or free radicals trapped in the crystal lattice.
• increase in UV absorption.
• loss in content of active substance upon irradiation with doses 200-400 kGy by about 0.5% -1.34%.
• radiolytic degradation of PD whose main product is an alcohol derivative (2-((R)-3-(1H-indol-4-yloxy)-2-hydroxypropylamino)propan-1-ol) forming as a result of o x i d a t i o n . [ 2]
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